MEPs will be able to see the CureVac vaccine contract starting Tuesday, Health Commissioner Stella Kyriakides tweeted Monday.
“Transparency & accountability are core EU values,” she wrote, adding that she has been working with companies to make more information public: “More companies should follow this example.”
For months, the European Parliament has called for more transparency with the Commission’s classified vaccine deals, while the Commission has countered it’s up to the companies to release confidential information.
The Commission has also been facing criticism after it became more widely known that Germany secured extra vaccine doses with BioNTech and CureVac in the fall — seen as a violation of the EU’s vaccine strategy.
Earlier Monday, Commission chief spokesperson Eric Mamer said Commission President Ursula von der Leyen told Kyriakides to write letters to all health ministers asking for more information about “all the necessary transparency on the way in which they are complying with the provisions of our vaccines strategy in terms of contacts, or lack of contacts rather, with those pharmaceutical companies that we have been or are negotiating with.”
Hans von der Burchard contributed reporting.
This article is part of POLITICO’s premium policy service: Pro HealthCare. From drug pricing, EMA, vaccines, pharma and more, our specialized journalists keep you on top of the topics driving the health care policy agenda. Email [email protected] for a complimentary trial.
MEPs to view CureVac coronavirus vaccine contract on Tuesday The British Journal Editors and Wire Services/ Politico.